According to the World Health Organization, every 3 seconds a person on our planet gets Alzheimer's disease. Currently, more than 50 million people on Earth are affected by the disease. By 2030, that number could exceed 65 million people.
Alzheimer's disease is more common in older people with a gradual loss of memory, impaired brain function and reduced mental capacity. Research is currently being conducted worldwide to detect and effectively treat this disease at an early stage.
Russian scientists, together with their Belgian and Italian colleagues, have found a way to treat Alzheimer's disease, which was considered incurable. During research, scientists were able to determine that when a number of receptors in the human brain are activated, the processes associated with Alzheimer's disease are reversed.
This requires "awakening" special amine receptors, that is, amino acid residues, in neurons to activate the right cells in the brain.
So far, this innovation has been successfully tested on animals. In the next stage, the effectiveness of the study will be tested on humans. Once the final results are positive, the scientific conclusion will be forwarded to the development of drugs needed to treat Alzheimer's disease.
Alzheimer's disease is more common in older people with a gradual loss of memory, impaired brain function and reduced mental capacity. Research is currently being conducted worldwide to detect and effectively treat this disease at an early stage.
Russian scientists, together with their Belgian and Italian colleagues, have found a way to treat Alzheimer's disease, which was considered incurable. During research, scientists were able to determine that when a number of receptors in the human brain are activated, the processes associated with Alzheimer's disease are reversed.
This requires "awakening" special amine receptors, that is, amino acid residues, in neurons to activate the right cells in the brain.
So far, this innovation has been successfully tested on animals. In the next stage, the effectiveness of the study will be tested on humans. Once the final results are positive, the scientific conclusion will be forwarded to the development of drugs needed to treat Alzheimer's disease.